Press release

Rechon Life Science AB of Sweden Partners with Adents for Scalable Serialization and Aggregation Solution

Rechon Life Science AB has partnered with Adents to offer its customers a scalable track & trace solution that complements its pharmaceuticals production and packaging services.

Paris, France & East Windsor, NJ – Rechon Life Science AB, a Sweden-based pharmaceuticals developer and contract manufacturer, has partnered with Adents, a leading provider of versatile serialization and aggregation software products, to offer its customers a scalable track & trace solution that complements its pharmaceuticals production and packaging services.  For Adents, the deal represents further geographical expansion of its widening global customer base, including its first foray into Scandinavia.

In choosing Adents, Rechon addresses compliance with several looming serialization mandates, including the European Union Falsified Medicines Directive and the USA’s Drug Supply Chain Security Act.  Eventually, all track & trace applications will be interfaced with Rechon’s Enterprise Resource Planning (ERP) system.

To meet its evolving needs, Rechon required a software solution that was flexible enough to change line configurations per client needs, able to generate and securely import/export unique serial numbers, and offered a workable pricing model.  Just as importantly, Rechon sought to use its existing infrastructure to incorporate this serialization solution.  Rechon has close ties with ACT-Logimark, a Sweden-based printing equipment provider and systems integration specialist.

The Adents serialization and aggregation suite of software enables companies to achieve traceability and documentation compliance easily, addressing both current and emerging regulations while also minimizing impact on production processes and productivity.  An ideal “standardized software” approach, Adents unit identification and traceability software is extremely flexible, scalable, and quick to deploy as it does not require add-on hardware.  It also helps enrich marketing and eliminate counterfeiting.

 Rechon offers a comprehensive range of pharmaceutical services, including the preparation, filling, packaging and distribution of commercial products as well as Clinical Trial Supplies.  The company’s cGMP contract pharmaceutical development services include process and analytical development; manufacturing, supplies and services for clinical trials; stability studies; storage and distribution and Qualified Person (QP) release services.

Maria Wingren, Manager Projects & Validation, said:

As a company that manufactures and packages pharmaceutical products for leading pharmaceutical companies around the world Rechon requires regulatory solutions that address a wide array of both customer and internal needs. In Adents Pharma Suite software, we believe we’ve found a easy to use, standardized solution that meets the complexities of current and future track & trace mandates – a flexible, scalable approach that works within our existing hardware and various, client-specific line configurations.

Our partnership with Rechon is far more than a typical vendor-customer relationship.  It establishes an ecosystem of system integrators capable of implementing serialization solutions expediently and on a grand scale.  This deal also brings together a consortium of experts capable of addressing track & trace issues from a holistic view – the effective marriage of software, hardware and line integration.”

added Christophe Devins, CEO and Founding Partner of Adents.

+33 (0)6 15 90 86 22


Adents Obtains Gateway Provider Certification from European Medicines Verification Organization (EMVO)
After a series of thorough tests with the European Medicines Verification Organization (EMVO) for connection to the European Hub, Adents is now one of only two official “Certified Gateway Providers” in the world.
Though DSCSA Law Remains Unchanged, Compliance Penalties are Delayed Until Nov. 2018. Pharma Companies will be able to Implement Far-reaching Serialization Solutions
As the U.S. pharmaceutical industry breathes a collective sigh of relief, Adents, the number one provider of versatile and easily deployable serialization and track-and-trace software solutions, is urging pharma manufacturers to take full advantage of the Drug Supply Chain Security Act’s one-year enforcement postponement.
Adents Implements Multi-Site, Multi-line Serialization & Aggregation Solution for Major European Pharma CMO
A premier, fully configurable drug serialization and aggregation software solution from Adents was successfully installed on seven packaging lines at four France sites for a top European pharmaceutical contract manufacturer. With a dozen production sites, the CMO requested short-term implementation to serialize saleable units for four markets – China, South Korea, Brazil and the U.S.